Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1951 1
1952 1
1955 1
1956 2
1958 1
1960 2
1961 1
1963 1
1966 1
1969 1
1970 3
1971 3
1972 2
1973 2
1974 2
1975 2
1976 7
1977 6
1978 7
1979 9
1980 9
1981 11
1982 10
1983 9
1984 10
1985 11
1986 3
1987 8
1988 7
1989 18
1990 16
1991 12
1992 16
1993 14
1994 8
1995 9
1996 12
1997 9
1998 16
1999 11
2000 10
2001 18
2002 9
2003 17
2004 25
2005 29
2006 41
2007 28
2008 27
2009 23
2010 21
2011 16
2012 15
2013 28
2014 25
2015 19
2016 20
2017 23
2018 16
2019 19
2020 27
2021 35
2022 29
2023 39
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

785 results

Results by year

Filters applied: . Clear all
Page 1
The genomic landscape across 474 surgically accessible epileptogenic human brain lesions.
López-Rivera JA, Leu C, Macnee M, Khoury J, Hoffmann L, Coras R, Kobow K, Bhattarai N, Pérez-Palma E, Hamer H, Brandner S, Rössler K, Bien CG, Kalbhenn T, Pieper T, Hartlieb T, Butler E, Genovese G, Becker K, Altmüller J, Niestroj LM, Ferguson L, Busch RM, Nürnberg P, Najm I, Blümcke I, Lal D. López-Rivera JA, et al. Among authors: busch rm. Brain. 2023 Apr 19;146(4):1342-1356. doi: 10.1093/brain/awac376. Brain. 2023. PMID: 36226386 Free PMC article.
Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy.
Jehi L, Jette N, Kwon CS, Josephson CB, Burneo JG, Cendes F, Sperling MR, Baxendale S, Busch RM, Triki CC, Cross JH, Ekstein D, Englot DJ, Luan G, Palmini A, Rios L, Wang X, Roessler K, Rydenhag B, Ramantani G, Schuele S, Wilmshurst JM, Wilson S, Wiebe S. Jehi L, et al. Among authors: busch rm. Epilepsia. 2022 Oct;63(10):2491-2506. doi: 10.1111/epi.17350. Epub 2022 Jul 17. Epilepsia. 2022. PMID: 35842919 Free PMC article.
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions.
Goede V, Fischer K, Busch R, Engelke A, Eichhorst B, Wendtner CM, Chagorova T, de la Serna J, Dilhuydy MS, Illmer T, Opat S, Owen CJ, Samoylova O, Kreuzer KA, Stilgenbauer S, Döhner H, Langerak AW, Ritgen M, Kneba M, Asikanius E, Humphrey K, Wenger M, Hallek M. Goede V, et al. Among authors: busch r. N Engl J Med. 2014 Mar 20;370(12):1101-10. doi: 10.1056/NEJMoa1313984. Epub 2014 Jan 8. N Engl J Med. 2014. PMID: 24401022 Free article. Clinical Trial.
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.
Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J, Hensel M, Hopfinger G, Hess G, von Grünhagen U, Bergmann M, Catalano J, Zinzani PL, Caligaris-Cappio F, Seymour JF, Berrebi A, Jäger U, Cazin B, Trneny M, Westermann A, Wendtner CM, Eichhorst BF, Staib P, Bühler A, Winkler D, Zenz T, Böttcher S, Ritgen M, Mendila M, Kneba M, Döhner H, Stilgenbauer S; International Group of Investigators; German Chronic Lymphocytic Leukaemia Study Group. Hallek M, et al. Among authors: busch r. Lancet. 2010 Oct 2;376(9747):1164-74. doi: 10.1016/S0140-6736(10)61381-5. Lancet. 2010. PMID: 20888994 Clinical Trial.
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial.
Eichhorst B, Fink AM, Bahlo J, Busch R, Kovacs G, Maurer C, Lange E, Köppler H, Kiehl M, Sökler M, Schlag R, Vehling-Kaiser U, Köchling G, Plöger C, Gregor M, Plesner T, Trneny M, Fischer K, Döhner H, Kneba M, Wendtner CM, Klapper W, Kreuzer KA, Stilgenbauer S, Böttcher S, Hallek M; international group of investigators; German CLL Study Group (GCLLSG). Eichhorst B, et al. Among authors: busch r. Lancet Oncol. 2016 Jul;17(7):928-942. doi: 10.1016/S1470-2045(16)30051-1. Epub 2016 May 20. Lancet Oncol. 2016. PMID: 27216274 Clinical Trial.
When Can we Feed after a Gastrointestinal Bleed?
Busch RA, Collier BR, Kaspar MB. Busch RA, et al. Curr Gastroenterol Rep. 2022 Jan;24(1):18-25. doi: 10.1007/s11894-022-00839-4. Epub 2022 Feb 11. Curr Gastroenterol Rep. 2022. PMID: 35147865 Review.
Transient global amnesia: current perspectives.
Spiegel DR, Smith J, Wade RR, Cherukuru N, Ursani A, Dobruskina Y, Crist T, Busch RF, Dhanani RM, Dreyer N. Spiegel DR, et al. Among authors: busch rf. Neuropsychiatr Dis Treat. 2017 Oct 24;13:2691-2703. doi: 10.2147/NDT.S130710. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 29123402 Free PMC article. Review.
Who Places Feeding Tubes and in What Scenario?
Shah A, Busch RA, Koepsel EK, Eisa M, Woods M, Palchaudhuri S. Shah A, et al. Among authors: busch ra. Curr Gastroenterol Rep. 2023 Aug;25(8):175-181. doi: 10.1007/s11894-023-00880-x. Epub 2023 Jul 14. Curr Gastroenterol Rep. 2023. PMID: 37452152 Review.
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.
Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB, Botros FT. Tuttle KR, et al. Among authors: busch rs. Lancet Diabetes Endocrinol. 2018 Aug;6(8):605-617. doi: 10.1016/S2213-8587(18)30104-9. Epub 2018 Jun 14. Lancet Diabetes Endocrinol. 2018. PMID: 29910024 Clinical Trial.
785 results